Xanadu and University of Alberta Partner to Accelerate Photodynamic Cancer Drug Discovery - Quantum Computing Report

Skip to content

GQINewsNews Archive 2026News Archive 2025News Archive 2024News Archive 2023News Archive 2022News Archive 2021News Archive 2020News Archive 2019News Archive 2018News Archive 2015-2017AnalysisQnalysisPlayersPublic CompaniesPrivate/Startup CompaniesUniversitiesGovernment/Non-ProfitVenture CapitalVenture Capital – Sorted by Quantum CompanyResourcesConferencesToolsOther Websites and Industry AssociationsEducationBooksScorecardsGate Level Software PlatformsIBM Qiskit, Rigetti Forest, Microsoft QDK, Project QReview of the Cirq Quantum Software FrameworkQubit Implementation DashboardQubit CountQubit QualityQubit TechnologySoftware/Startup PartnersCloud Platform Hardware PartnersPodcastsAboutQCR Alerts Sign-Up FormAdvertising InquiriesQCR in the NewsContactPrivacy PolicyMembership

Xanadu and University of Alberta Partner to Accelerate Photodynamic Cancer Drug Discovery

Photonic quantum computing developer Xanadu Quantum Technologies Limited (NASDAQ/TSX: XNDU) has announced a strategic research partnership with the University of Alberta to engineer novel quantum algorithms for oncology and pharmaceutical drug design. Led by Xanadu’s algorithms team and Professor Alex Brown, Chair of the Department of Chemistry at the University of Alberta, the project focuses on modeling complex light-matter interactions in photosensitizers—light-activated chemical compounds utilized in targeted photodynamic cancer therapy (PDT).